| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 25/05/2015 | 04:00 | Dow Jones News | Strike Worsens Nigeria Fuel Crisis | NASDAQ:KAL | Kenya Airways Ltd. |
| 04/10/2012 | 18:04 | Dow Jones News | Cameroon To Buy Two Boeing Aircraft -Official | AMEX:KAL | Callisto Pharmaceuticals, |
| 05/09/2011 | 13:03 | Dow Jones News | Kenya Airways To Buy 10 E190 Jets From Brazil's Embraer -Report | NASDAQ:KAL | Kenya Airways Ltd. |
| 14/04/2011 | 19:52 | Dow Jones News | Kenya Airways Reaches Deal With Boeing Over 787 Delivery | NASDAQ:KAL | Kenya Airways Ltd. |
| 08/06/2010 | 15:55 | Dow Jones News | Air France-KLM Isn't Seeking M&A Deals Right Now - KLM CEO | NASDAQ:KAL | Kenya Airways Ltd. |
| 16/04/2010 | 14:20 | Dow Jones News | UPDATE: SkyTeam In Talks With Candidates For Expansion | NASDAQ:KAL | Kenya Airways Ltd. |
| 08/07/2008 | 22:46 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Current report filing (8-K) | AMEX:KAL | Callisto Pharmaceuticals, |
| 15/05/2008 | 22:05 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Quarterly Report (10-Q) | AMEX:KAL | Callisto Pharmaceuticals, |
| 02/05/2008 | 20:04 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A) | AMEX:KAL | Callisto Pharmaceuticals, |
| 24/04/2008 | 12:01 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Notice of Effectiveness (EFFECT) | AMEX:KAL | Callisto Pharmaceuticals, |
| 16/04/2008 | 22:47 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Securities Registration Statement (simplified form) (S-3) | AMEX:KAL | Callisto Pharmaceuticals, |
| 11/04/2008 | 22:07 | Business Wire | Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal - | AMEX:KAL | Callisto Pharmaceuticals, |
| 28/03/2008 | 11:01 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Annual Report (10-K) | AMEX:KAL | Callisto Pharmaceuticals, |
| 14/02/2008 | 19:57 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Statement of Ownership (SC 13G) | AMEX:KAL | Callisto Pharmaceuticals, |
| 30/01/2008 | 19:55 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3) | AMEX:KAL | Callisto Pharmaceuticals, |
| 25/10/2007 | 16:33 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:KAL | Callisto Pharmaceuticals, |
| 01/10/2007 | 23:01 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc (Other) (8-K) | AMEX:KAL | Callisto Pharmaceuticals, |
| 28/09/2007 | 19:53 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc (Other) (424B3) | AMEX:KAL | Callisto Pharmaceuticals, |
| 28/09/2007 | 16:54 | Edgar (US Regulatory) | Callisto Pharmaceuticals Inc (Other) (4) | AMEX:KAL | Callisto Pharmaceuticals, |
| 20/09/2007 | 13:07 | PR Newswire (US) | Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer | NASDAQ:KAL | |
| 29/08/2007 | 15:00 | PR Newswire (US) | American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards | NASDAQ:KAL | |
| 11/08/2007 | 02:05 | PR Newswire (US) | Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines | NASDAQ:KAL | |
| 09/08/2007 | 14:00 | PR Newswire (US) | Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients | NASDAQ:KAL | |
| 08/08/2007 | 14:00 | PR Newswire (US) | Callisto Reports on Second-Quarter 2007 Milestones | NASDAQ:KAL | |
| 07/08/2007 | 14:00 | PR Newswire (US) | Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing | NASDAQ:KAL | |
| 25/06/2007 | 14:00 | PR Newswire (US) | Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients | NASDAQ:KAL | |
| 22/06/2007 | 23:05 | PR Newswire (US) | Callisto Pharmaceuticals, Inc. Receives Notice From AMEX | AMEX:KAL | Callisto Pharmaceuticals, |
| 08/06/2007 | 16:30 | PR Newswire (US) | Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio | NASDAQ:KAL | |
| 24/05/2007 | 16:00 | PR Newswire (US) | Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients | NASDAQ:KAL | |
| 15/05/2007 | 18:24 | PR Newswire (US) | Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News Journal | NASDAQ:KAL | |